Healthcare Triangle Plans 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance

Healthcare Triangle will effect a 1-for-20 reverse stock split of its common stock, cutting its outstanding shares from approximately 17,730,008 to approximately 886,501, Stock Titan reported. The split is part of the company's strategy to regain compliance with the Nasdaq Capital Market's $1.00 minimum bid price requirement.

Healthcare Triangle's Split Mechanics and Nasdaq Bid Rule

Healthcare Triangle said the reverse stock split becomes effective at 12:01 a.m. Eastern Time on October 26, 2026, and its common stock will begin trading on a post-split basis at the market open that day, pending confirmation by the Depository Trust Company and Nasdaq. The stock keeps its existing "HCTI" symbol, and a new CUSIP number, 42227W 504, has been assigned.

At the effective time, each twenty issued and outstanding shares convert automatically into one share, with no change to the $0.00001 par value or the total number of authorized shares. No fractional shares will be issued; stockholders who would otherwise receive a fraction are rounded up to the next whole post-split share. Holders of record as of October 26, 2026 will receive ownership information from the transfer agent, VStock Transfer.

Nasdaq's $1.00 minimum bid price requirement is the listing standard the company cites as the reason for the split. On October 21, 2026, Direct Digital Holdings said it would voluntarily delist from Nasdaq and deregister its Class A common stock effective November 12, 2026, according to Stock Titan.

Healthcare Triangle's Funding and Revenue Figures

According to akta.pro company records, Healthcare Triangle has eight funding rounds on record, including a $3.6 million post-IPO debt round in June 2026, a $4 million post-IPO equity round in February 2026, a $20 million post-IPO equity round in November 2025 led by Spartan Capital Securities, and a $755,000 post-IPO equity round in October 2025. The same records show Q1 2026 revenue of $9.9 million, a 166% increase from $3.7 million a year earlier, and Q1 2026 gross profit of $2.4 million.

Healthcare Triangle's Path to the Reverse Split

In August 2026, Healthcare Triangle reported a 158% year-over-year increase in Q2 2026 revenue to $9.19 million and a 322% rise in gross profit, driven primarily by its acquisition of Teyame and Datono, Yahoo reported. In September 2026, AInvest reported that the company planned to distribute a minority stake in its AI subsidiary Teyame AI Holdings to shareholders via stock dividend, pending SEC and Nasdaq approvals. Also in September 2026, AInvest reported that an SEC filing indicated the pending spin-off is expected to qualify as a taxable distribution for U.S. federal income tax purposes.

What Comes Next for Healthcare Triangle

Post-split trading on the Nasdaq Capital Market remains pending confirmation by the Depository Trust Company and Nasdaq, the company said. Additional information about the reverse stock split is set out in the company's definitive proxy statement on Schedule 14A, filed with the SEC on October 13, 2026.